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Abstract 
Manganese is an essential trace element however elevated environmental and occupational 
exposure to this element has been correlated with neurotoxicity symptoms clinically identical to 
idiopathic Parkinson’s disease. In the present study we chronically exposed human 
neuroblastoma SH-SY5Y cells to manganese (100µM) and carried out expression profiling of 
miRNAs known to modulate neuronal differentiation and neurodegeneration. The miRNA PCR 
array results reveal alterations in expression levels of miRNAs, which have previously been 
associated with the regulation of synaptic transmission and apoptosis. The expressions of miR-7 
and miR-433  significantly reduced upon manganese exposure. By in silico homology analysis 
we identified SNCA and FGF-20as targets of miR-7 and miR-433. We demonstrate an inverse 
correlation in expression levels where reduction in these two miRNAs causes increases in SNCA 
and FGF-20. Transient transfection of SH-SY5Y cells with miR-7 and miR-433 mimics resulted 
in down regulation of SNCA and FGF-20 mRNA levels. Our study is the first to uncover the 
potential link between manganese exposure, altered miRNA expression and parkinsonism: 
manganese exposure causes overexpression of SNCA and FGF-20 by diminishing miR-7 and 
miR-433 levels. These miRNAs may be considered critical for protection from manganese 
induced neurotoxic mechanism and hence as potential therapeutic targets.  
Keywords : Manganese, SH-SY5Y, miRNA, SNCA, Parkinson’s disease  
Abbreviations 
BCL2  - B-Cell CLL/Lymphoma 2 
CCND1 - Cyclin D1 
CCNE1 - Cyclin E1 
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CRKL  - V-Crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like 
FGF20  - Fibroblast Growth Factor 20 
FGF7  - Fibroblast growth factor 7 
FOXO1 - Forkhead Box Protein O1A  
GRB2  - Growth Factor Receptor Bound Protein 2 
HMGA1 - High Mobility Group AT-Hook 1 
Mn  - Manganese 
NTRK3 - Neurotrophic Receptor Tyrosine Kinase 3   
PAK1  - P21 Protein (Cdc42/Rac)-Activated Kinase 1 
SLC7A5 - Solute Carrier Family 7 Member 5 
SNCA  - Synuclein Alpha 
WNT3A - Wingless-Type MMTV Integration Site Family, Member 3A 
α-syn  - α-synuclein 
 
1. Introduction 
Manganese (Mn) is the most prevalent transition metal in the environment but is only 
required in trace amounts for normal growth and brain development (Sandstead, 1986). Mn is an 
essential cofactor for various enzymes involved in carbohydrate and protein metabolism and for 
antioxidant enzymes such as superoxide dismutase (SOD) (Guilarte TR, 2013). Mn levels are 
tightly regulated in the human body and exposure to elevated concentrations cause manganism, a 
neurological disorder with clinical symptoms resembling those of idiopathic Parkinson’s disease 
(Racette BA et al., 2012a, 2001b). Mn can be an occupational healthrisk. For example, miners 
and workers in ferroalloy, smelting and metallurgy industries are often exposed to Mn, primarily 
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through inhalation (Finkelstein MM, 2007; Lucas E.L et al.,  2015). It is possible that rural 
populations are at greater risk of developing Parkinson’s disease considering their frequent 
exposure to Maneb and Paraquat, pesticides containing Mn (Ritz et al, 2000; Roede JR et al., 
2011). Also populations that depend Mn contaminated drinking water at levels exceeding the 
WHO regulatory standard (400µg/L) have been shown to express increased risk of  neurological 
deficits (WHO, 2006;Ljung K, 2007).  Elevated levels of Mn can also be released into the 
atmosphere as a combustion product since methylcyclopentadienyl manganese tricarbonyl 
(MMT) is used to improve fuel oil combustion (Crump, 2000; Su C et al., 2015). High dosage 
consumption of Mn containing psychoactive formulations have been associated with 
parkinsonism (de Bie R et al., 2007).  
The globus pallidus is a primary site for Mn accumulation within the brain while other 
studies also suggests deposition in the substantia nigra, a brain structure that produces dopamine 
(Park JD et al., 2007). Progressive loss of dopaminergic neurons in the substantia nigra due to 
Mn accumulation could be a pathophysiological cause of parkinsonism (Peneder TM et al., 
2011). Parkinson’s disease (PD) is characterized by the loss of dopaminergic neurons and the 
presence of Lewy neurites (LNs) and proteinaceous inclusions known as Lewy bodies (LBs) in 
dopaminergic neurons (Hashimoto, M et al., 2009; Recchia A et al., 2004). A major component 
of LBs are peptides encoded by α-Synuclein (SNCA) (Spillantini M. G et al., 1997). Altered 
SNCA expression levels have been found to be associated with several neurodegenerative 
diseases including Parkinson’s disease (Recchia A et al., 2004). Mn exposure can induce 
overexpression of SNCA, causing neuronal apoptosis (Cai T et al., 2010; Jason P, 2011; Li Y et 
al., 2010). The upstream regulatory events leading to SNCA over-expression have not been well 
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established. Our previous work suggests the possible role of Mn induced epigenetic changes in 
parkinsonism through mitochondrial dysfunction (Tarale et al., 2017, 2016). 
MicroRNAs (miRNAs) are 17–24 base small non-coding, single stranded RNAs that regulate 
gene expression post-transcriptionally via binding to the 3’-untranslated region (UTR) of 
mRNAs, thereby repressing the translation process (Gartel AL, 2008; He L, 2004). 
Dysregulation of miRNA expression was recently identified as contributing to a higher risk of 
neurodegeneration (Johnson R et al., 2012). Altered expression of miRNAs, such as miR-29a/b-
1, miR-19, miR-101 and miR-130 has been associated with neurodegenerative disorders (Hébert 
SS et al., 2008). Additionally, miR-7 and mir-433 have been found to regulate the expression of 
SNCA in normal and PD brain, as well as in animal models of PD, for example, the worm C. 
elegens (Asikainen S, Rudgalvyte M, 2010; Gillardon F, Mack M, 2008; Junn E et al., 2009; 
Vartiainen S et al., 2006; Wang G et al., 2008). The potential role of miRNAs in manganese 
exposed cell models and the implications in the etiology of Parkinson’s disease have not been yet 
explored. 
In the present investigation we profiled the expression of 84 different miRNAs known to be 
differentially expressed during neuronal development or in neurodegeneration. We used a 
miRNA PCR array and measured expression changes in the dopaminergic human neuroblastoma 
cell line SH-SY5Y following a chronic manganese exposure. This represents the first study to 
demonstrate a connection between Mn exposure, miRNA deregulation and Parkinson’s disease. 
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2. Material and Methods 
2.1. Cell line 
 Human neuroblastoma (SH-SY5Y) cell line was obtained from National Center for Cell 
Science (NCCS), Pune, India. Cells were grown in Ham’s F-12 medium supplemented with 10% 
fetal bovine serum, 100 U/mL penicillin, 50 𝜇g/mL streptomycin, and 25 𝜇g/mL Fungizone. 
Cells were maintained at 37∘C in a humidified atmosphere with 5% CO2. 
2.2. Chronic Mn2+ exposure 
 SH-SY5Y cells were seeded in 25mm2 flask (5 x105 cells/ml) and grown to 70% 
confluence when they were exposed to 100 µM of Mn2+ in the form of MnCl2 (Sigma Aldrich, 
USA). The Concentration was selected from the dose response relationship (24hrs) for Mn 
exposed SH-SY5Y cells (Supplementary figure 1). This is also within the range of concentration 
from previous studies that used human astrocytes and human brain samples. Mn concentrations 
shown to be toxic are in the range  60.1-158.4 µM (Bowman AB., and Aschner, 2014).  Mn 
exposures ≥50 µM (from 0 to 100µM) have been found to impact the redox processes in human 
neuroblastoma cell mitochondria corresponding to toxic range of Mn in human brain (Fernandes 
et al., 2017). Three replicates of controls (culture medium only) and three replicates of Mn-
exposed cultures were maintained for a period of 30 days. The medium was changed every 72 
hours after each passage throughout the period of exposure. Mn2+ was added after each cell 
passage after cells started to adhere to the surface of the flasks (it took approximately 3-4 hours 
for cells to adhere). We also evaluated the viability of cells at each cell passage using a trypan 
blue exclusion assay (Supplementary figure 2). The viability of exposed cells remains at ~85% 
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throughout the period of chronic exposure. This indicates there is not a development of tolerance 
for Mn over the period of exposure. 
2.3. miRNA profiling 
 At the end of the exposure period, total miRNA was harvested from the cells using the 
mirPremier microRNA Isolation Kit (Sigma Aldrich, USA) as per the manufacturer protocol. 
miRNA was quantified using a NanoDrop 8000 spectrophotometer. miRNA profiling was 
carried out using the Qiagen human neurological  development and disease miScriptmiRNA 
PCR array, to analyse the differential expression of 84 miRNAs involved in neuronal 
development or progression of neurological diseases (Supplementary table 1). 12 wells of each 
miScriptmiRNA PCR array plate were controls (SNORD61, SNORD68, SNORD72, SNORD95, 
SNORD96A, RNU6-6P). These controls were used for normalization of RT-PCR data for 
endogenous miRNAs in the samples. 200 ng of miRNA was converted to cDNA using miScript 
II RT kit (Qiagen, Germany) as per the manufacturer instructions. Real time PCR for mature 
miRNA expression profiling was performed using diluted cDNA according to the manufacturer’s 
protocol. Applied Biosystems 7300 real time PCR system was used for RT-PCR. Data were 
collected to perform quantification using the ΔΔCt method of relative quantification and 
interpretation of control wells (Tarale et al., 2017). 
2.4. In silico Hybridisation Analysis 
 In silico hybridisation studies were performed using the mirTarBase and miRANDA 
software (August 2010 release; http://www.microrna.org/microrna/home.do) to screen and 
predict possible mRNA targets of differentially expressed miRNAs. miR-433-3p and miR-7-5p 
were selected for this in silico analysis based on their significant differential expression detected 
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in our study and their established role in Parkinson’s disease (Wang G et al., 2008) 
(Supplementary table 1). Additionally, other miRNAs were screened for their possible mRNA 
targets. Supplementary file 1 gives the list of these miRNAs along with their target genes and 
associated biological functions. The list of potential target genes was submitted to Database for 
Annotation, Visualization and Integrated Discovery (DAVID) version 6.7 for functional 
annotation clustering.  
2.5. Real time quantitative PCR 
 Validation of screened miRNAs (miR-433-3p/miR-7-5p) was carried out using 
quantitative real time PCR (qRT-PCR). Isolation of miRNAs was carried using the mirPremier 
microRNA Isolation Kit (Sigma Aldrich, USA) as per the manufacturer protocol. 500 ng of 
miRNA was converted to cDNA using the NCode VILO miRNAcDNA Synthesis Kit 
(Invitrogen, USA). Relative quantification of miRNA was performed on Applied Biosystems 
7300 real time PCR system using EXPRESS SYBR GreenERqPCRSuperMix containing 
universal reverse primers (Invitrogen, USA) and forward customized primers of miR-433-
3p/miR-7-5p (Table 1). RUN48 was used as an internal control in the real time qRT-PCR (Nurul 
et al., 2012). ddCT (2∧-ddCt) method was used for calculation of fold change. 
For expression-validation of possible mRNA targets, total RNA was isolated using the Trizol 
(Invitrogen, USA) reagent. RNA was quantified using a NanoDrop 8000 spectrophotometer. 
High Capacity Reverse Transcription kit (Applied Biosystems, USA) was used for converting 2 
µg of total RNA to cDNA. qRT-PCR primers for SNCA and FGF-20 were used (Table 1) and 
validated before relative quantification. RNA polymerase II (RPII) and hypoxanthine 
phosphoribosyltransferase (HPRT) were used as internal controls (Sain S et al., 2014). Relative 
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quantification was performed on Applied Biosystems 7300 real time PCR system using 
EXPRESS SYBR GreenERqPCRSuperMix. Fold change in expression was calculated using the 
ddCT (2∧-ddCt) method. 
2.6. miRNA mimics transfection 
 mirVanaTMmiRNA mimics are small, double stranded RNAs that mimic endogenous 
precursor miRNAs. They increase potency and specificity for enhanced performance in gain of 
function analysis of miRNAs. hsa-miR-7-5p (mature miRNA sequence-
UGGAAGACUAGUGAUUUUGUUGU) and has-miR-433-3p (mature miRNA sequence- 
AUCAUGAUGGGCUCCUCGGUGU) mimics were purchased from Invitrogen, USA. 
Transfection efficiency for SH-SY5Y cell line was calculated using Block iTAlexa Fluor Red 
(Invitrogen, USA). BlockiTAlexa Fluor Red fluorescence (50nM) along with Lipofectamine-
2000 (Invitrogen, USA) (1 µl/25µl OptiME  medium) was transfected to SH-SY5Y cells 
seeded in 6-well flat bottom plates at 70% confluence level. 4 hrs post incubation after 
transfection, cells were imaged with fluorescence microscope (Olympus, USA). 
SH-SY5Y cells were seeded in 25mm2 culture flasks at a density of 5x105 cells/ml for 
transfection with miRNA mimics. At 70% confluence cells were transfected with 50nM miRNA 
mimics (hsa-miR-7-5p ,has-miR-433-3p, mirVanaInvitrogen, USA). Lipofectamine-2000 
(Invitrogen, USA) was used as transfection agent at the concentration of 1 µl/25µl in OptiMEM 
medium. After a 6hr incubation, OptiMEM was replaced with Ham’s F-12 medium (2% serum) 
followed by treatment with Mn2+ (100µM) for 24h.  After incubation, miRNAs were isolated 
using mirPremier microRNA isolation kit (Sigma Aldrich, USA) and total RNA was isolated 
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using Trizol (Invitrogen, USA). qRT- PCR was carried out for miRNAs and RNA as discussed 
in 2.5. 
 
2.7. Statistical analysis  
Student’s t test (paired, 2-tailed) in Microsoft Excel was used to determine the statistical 
significance between the values in control and exposed samples.  
 
 
3. Results 
3.1 Deregulation of miRNA expression is implicated in critical neuronal pathways 
 The miRNAs sampled by the miScriptmiRNA PCR array include a set of miRNAs 
known to be associated with various neuronal disorders (Supplementary table 1). miRNA 
expression data were obtained for a total of 84 miRNAs and their differential expression 
visualized by a heat map (figure 1). Our results indicate significantly altered expression levels of 
24 miRNAs (p<0.05), six were up-regulated in expression, while the rest were down-regulated 
(Figure 2A). To identify target genes from the misregulated miRNAs, we screened the online in-
silico databases mirTarBase and miRANDA. The results of the screen yielded a list of 80 target 
genes whose mRNAs serve as putative binding sites for the 24 misregulated miRNAs. 
(Supplementary file 1). The Database for Annotation, Visualization and Integrated Discovery 
(DAVID) version 6.7 (https://david.ncifcrf.gov/) was used for functional annotation clustering of 
putative target genes.  
DAVID analysis indicates that these putative target genes are primarily involved in processes of 
apoptosis (21%), gene expression (21%), phosphorylation (19%) and synaptic transmission 
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(10%) (Figure 2B). We narrowed our screen of 80 putative miRNA target genes and focused on 
genes known to be associated with Parkinson’s disease (Supplementary table 1). NTRK3, SNCA, 
PAK1, SLC7A5 have been identified as putative target genes for miR-7. WNT3A, BCL2, CCND1, 
CCNE1, CRKL, HMGA1, FGF7, FOXO1 and FGF20, GRB2 have been identified as putative 
target genes for miR-15A and miR-433, respectively. For the rest of the study, we concentrated 
on SNCA and FGF-20, two genes known to play critical roles in the development of Parkinson’s 
disease.  
 
3.2 miR-7 and miR-433 identified as regulators of SNCA expression 
 An in-silico homology analysis identified SNCA and FGF-20 as putative target genes for 
miR-7 and miR-433, respectively (Junn E et al., 2009) (Figure 3A). miR-7 and miR-433 are 
predicted to bind the 3'-UTR regions of SNCA and FGF-20 and thereby could interfere with the 
mRNA translation process. These two miRNAs have been reported to play a role in the 
pathophysiology of Parkinson’s disease ( Wang et al., 2008; Doxakis., 2010;).  
To validate miR-7 and miR-433 expression levels and those of their potential targets, SNCA and 
FGF-20, we performed qRT-PCR. The results indicate significant down-regulation (p<0.05) of 
miR-7(-2.13 ± 0.24), and miR-433 (-4.85 ± 0.30) following Mn exposure (Figure 3B). In the 
same cells, the qRT-PCR results show that Mn exposure resulted in up-regulated expression of 
both, SNCA (4.02 ± 0.16) and FGF-20 (2.61 ± 0.22) (Figure 3C). SNCA is considered to play a 
critical role during the onset of Parkinson’s disease. It has also been shown that the expression of 
SNCA may be indirectly regulated by FGF-20 (Wang G et al., 2008). The diminished expression 
of miRNA-433 causing elevated levels of FGF 20 may therefore also influence the regulation of 
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SNCA expression. The present results imply a role for miR-7 and miR-433 in regulating SNCA 
expression.  
 
3.3 Transfection with miRNA mimics down-regulates SNCA expression 
To validate and further explore the roles of miR-7 and miR-433 in regulating the 
expression of SNCA, we transfected manganese-exposed SH-SY5Y cells with miRNA mimics 
for mir-7 and miR-433. Transfection efficiency for SH-SY5Y cells was greater than 90% (Figure 
4A). qRT-PCR for miR-7 and miR-433 after transfection with miRNA mimics shows an 
decrease in expression with fold changes of 3.34±0.24 and 4.35±0.30, respectively (p<0.05)  
(Figure 4B). Subsequent qRT-PCR analysis for SNCA and FGF-20 showed that transfection with 
miRNA mimics correlated with reduced expression of SNCA (Figure 4C). Transfection with 
miR-7 mimics causes significant down-regulation in the expression level of SNCA (fold change -
2.45±0.18) (Figure 4D). This observation supports the concept that miR-7 has a direct role in 
regulating the expression of SNCA. Transfection with miR-433 mimic down-regulates the 
expression of SNCA and FGF-20 with fold changes of -1.29 ± 0.18 and -1.98 ± 0.34 respectively 
(p<0.05) (Figure 4C and D). The observed down-regulation in the expression of SNCA upon 
transfection with mimics for miR-433 strengthens the hypothesis that FGF-20 indirectly 
regulates SNCA expression.  
 
4. Discussion 
 Manganese is an crucial trace element however chronic environmental and occupational 
exposure reported to cause neurological deficits with symptoms clinically resembling to 
idiopathic Parkinson’s disease (Su C et al., 2015). Elevated expression of SNCA considered to 
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be toxic for dopaminergic neuronal cells and frequent molecular pathological findings in brain 
tissue samples from Parkinson’s disease patients (Recchia A et al., 2010). Various genetic and 
environmental factors may have the potential to cause elevated SNCA expression (reviewed in 
Tarale et al., 2016). Mn exposure has been reported to cause over-expression of SNCA in the 
neuronal SH-SY5Y cell line (Li Yet al., 2009). Our work provides evidence that Mn-exposure 
leads to deregulation of certain miRNAs. These miRNAs and their potential target mRNAs 
regulate apoptosis and synaptic transmission, processes which are critically important for 
neuronal cell health (Figure 2A and B).  
Among the list of deregulated miRNAs, we selected miR-7 and miR-433 to further dissect their 
role in manganese neurotoxicity. Expression of miR-7 and miR-433 was down-regulated 
following Mn exposure (Figure 3B). We also identified SNCA and FGF-20 as putative targets of 
miR-7 and miR-433 (figure 3A). 
The upstream mechanisms causing down-regulation of miR-7 and miR-433 are unknown. 
However, Mn exposure is known to cause neuronal cell apoptosis through oxidative stress 
mechanisms (Stephenson et al., 2013; Fernandes et al., 2017). Alterations in the redox balance of 
primary human brain cells exposed to iron-plus aluminum-sulfate can cause deregulation of 
specific miRNAs via ROS generation ( Lukiw and Aileen, 2007). We hypothesise that oxidative 
stress and its effect on redox sensitive transcription factors may lead to altered expression of 
miRNAs, which in turn influence a gene programme important in PD.  
miR-7 is a conserved gene enriched in brain and known to regulate neuronal differential and 
synaptic plasticity (Doxakis, 2010). Reduction in the expression level of miR-7 in 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated mice (a model of PD) has been reported to 
cause an elevation in SNCA expression and degeneration of the nigrostriatal system (Shasi et al., 
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2000). Mn-containing neurotoxins, including MPTP leads to a demise of dopaminergic neurons 
in mice (Musmusculus) and nematode worms (C. elegans) (Cannon JR and Greenamyre, 2010). 
Our present study suggests a role for miR-7 in Mn-induced neurodegeneration by causing SNCA 
overexpression. 
Fibroblast growth factor 20 (FGF-20) is expressed in the substangia nigra and may preserve the 
function of neurotrophic activity in dopaminergic neurons (Ohta, 2013). FGF20 has been 
suggested as another candidate gene responsible for Parkinson’s disease in Japanese and Chinese 
populations (Pan et al., 2012); though not in Finnish and Greek populations (Satake et al., 2008; 
Christian et al., 2009). 
A sequence polymorphism in the 3’ UTR of FGF20 elevates the risk of Parkinson’s disease and 
is most likely caused by disruption of a binding site for microRNA-433 (Wang G et al., 2008). 
Homozygosity of this FGF-20 variant is not only associated with an elevation of FGF-20 
expression, but also with an increase in SNCA protein levels (Wang G et al., 2008). In the 
present work we show that elevated FGF-20 expression is closely associated with decreased 
miR-433 levels. 
Our transfection study with miRNA mimics strengthens the evidence that manganese exposure 
may cause elevation of SNCA expression via alteration in miR-7 and miR-433 levels. It will be 
of interest to replicate and confirm our results using animal models. The present findings indicate 
that two neurodegenerative disorders - manganism and idiopathic Parkinson’s disease may result 
from misregulation of the same genetic network, which includes altered expression of miRNAs. 
Our results raise the possibility of using miR-7 and miR-433 as therapeutic targets to prevent or 
treat manganese induced neurotoxicity. 
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5. Conclusion 
 The present study identified a selection of miRNAs which are deregulated upon Mn-
exposure in a neuronal cell line. This list of miRNAs provides molecular entry points to further 
explore their regulatory roles in Mn-induced neurodegeneration. A key finding is that down-
regulation of miR-7 and miR-433 is closely associated with elevated SNCA expression. We 
provide the first indication that manganism and Parkinson’s disease share common molecular 
mechanisms, including deregulation of miRNAs which may be targeted therapeutically. 
 
Figure legends 
Figure 1.Heatmap clustering of 84 miRNAs involved in neuronal development or progression of 
neurological diseases. Red and green colors represent the magnitude of expression. 
Figure 2. miScriptmiRNA PCR array profiling of miRNA expression in SH-SY5Y cells 
chronically exposed to manganese (100 µM) A) Expression profile for 24 miRNAs differentially 
expressed at statistically significant levels (p<0.05). B) DAVID based function annotation and 
clustering showing the major biological pathways associated with the target genes of deregulated 
miRNAs. Predictions are based upon in-silico homology using mirTarBase and miRANDA 
online softwares. 
Figure 3. A) In-silico hybridization analysis of miR-7 and miR-433 with SNCA and FGF-
20.Validation of expression level of miRNA and their target genes by qRT-PCR B) Expression 
levels of miR-7 and miR-433 and C) Expression levels of SNCA and FGF-20 in manganese 
treated samples were normalized with the control. 
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Figure 4. A) Transfection efficiency of SH-SY5Y cells were determined using Block iTAlexa 
Fluor Red B) Expression profile of miR-7 and miR-433 after transfection with miRNA mimics. 
C) Expression profile of SNCA after transfection with miRNA mimics in manganese exposed 
cells. D) Expression of FGF-20 post-transfection with mimics in manganese exposed cells. 
Expression of SNCA and FGF-20 were normalized with controls in manganese treated samples. 
Table 1.qRT-PCR primers 
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Table 1: qPCR primers 
Sr 
no 
Gene name Primer Sequence (5'-3') 
miRNA 
1 miR-433-3p Forward primer ATCATGATGGGCTCCTCGGTGT 
 
2 miR-7-5p Forward primer TGGAAGACTAGTGATTTTGTTGT 
 
3 RUN48 Forward primer AGTGATGATGACCCCAGGTAACTC 
Reverse primer CTGCGGTGATGGCATCAG 
 
Genes 
 
4 SNCA Forward primer GTGTGGCAACAGTGGCTGAG 
 
Reverse primer TGGGGCTCCTTCTTCATTCTTG 
 
    
  
5 FGF20 Forward primer ACAGCCTCTTCGGTATCTTG 
 
Reverse primer TCTTGGAGTTCCGTCTTTGT 
 
 
6 RPII (Internal control) Forward primer GCACCACGTCCAATGACAT 
 
Reverse primer GTGCGGCTGGTTCCATAA 
 
 
7 HPRT (Internal control) Forward primer ACGAAGTGTTGGATATAAGC 
 
Reverse primer ATAATTTTACTGGCGATGTC 
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Highlights 
 Mn causes altered miRNAs expression regulating synaptic transmission and apoptosis 
 miR-7 and miR-433 expression is significantly diminished upon chronic Mn exposure 
 SNCA and FGF-20 identified as target genes that shows up-regulation in expression 
 miRNA mimics transfection confirms the specificity of miRNAs with target genes 
 miR-7 and miR-433 are potential therapeutic targets against  Mn neurotoxicity 
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